Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EGTX.ST Net Margin

The Net Margin of Egetis Therapeutics AB (publ) (EGTX.ST) is -745.12%.

Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.

EGTX.ST Net Margin - Historical Value
Date Value
2024-12-31 -745.12%
2023-12-31 -567.19%
2022-12-31 -857.52%
2021-12-31 -273.36%
2020-12-31 -437.81%
2019-12-31 -74.39%
2018-12-31 -301.31%
2017-12-31 -647.29%
EGTX.ST Net Margin - Peers Comparison